Chlorzoxazone and Coenzyme q10 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Chlorzoxazone (chlorzoxazone) and Coenzyme q10 (coenzyme q - 10). Common drug interactions include cough among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Chlorzoxazone and Coenzyme q10. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Chlorzoxazone?

Chlorzoxazone has active ingredients of chlorzoxazone. It is often used in muscle spasms. eHealthMe is studying from 1,836 Chlorzoxazone users. Check the latest studies of Chlorzoxazone.

What is Coenzyme q10?

Coenzyme q10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 23,438 Coenzyme q10 users. Check the latest studies of Coenzyme q10.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

34 people who take Chlorzoxazone and Coenzyme q10 together, and have interactions are studied.

Chlorzoxazone and Coenzyme q10 drug interactions.

What are the common drug interactions of Chlorzoxazone and Coenzyme Q10, by gender? *:

female:

Cough
Anxiety
Dizziness
Memory impairment
Pain
Cataract (clouding of the lens inside the eye)
Nephrolithiasis (calculi in the kidneys)
White blood cell count increased
Abdominal discomfort
Asthenia (weakness)

male:

Chronic kidney disease
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Bone density decreased
Adverse event
Drug ineffective
Somnolence (a state of near-sleep, a strong desire for sleep)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone pain
Drug resistance (reduction in effectiveness of a drug)

What are the common drug interactions of Chlorzoxazone and Coenzyme Q10, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Flushing (the warm, red condition of human skin)

40-49:

Anxiety
Abdominal discomfort
Chronic kidney disease
Dizziness
Face injury
Fall
Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
Ligament sprain (ligament stretched)
Loss of consciousness
Memory impairment

50-59:

Adverse event
Drug ineffective
Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

Cough
Cataract (clouding of the lens inside the eye)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Swelling face
Hypersensitivity
Thrombosis (formation of a blood clot inside a blood vessel)
Concussion (short loss of normal brain function in response to a head injury)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Haemorrhage (bleeding)
Head injury

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 41.18%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 32.35%
Stiff Person Syndrome: 5 people, 14.71%
Sleep Disorder: 5 people, 14.71%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 5 people, 14.71%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 11.76%
Hiv Infection: 3 people, 8.82%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 5.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.88%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Chlorzoxazone and Coenzyme q10?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously